SCHEMBL28527799

SCHEMBL28527799

CC#Cc1ncc(Br)cn1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
HTT P42858 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12422698 0.77 CCR1 (0.35)
SCHEMBL17080370 0.75 ACACB (0.36)
SCHEMBL4491199 0.75 KDM4E (0.32) KDM4E
SCHEMBL18636488 0.71 KDM4E (0.45) KDM4EHTT
SCHEMBL29392 0.70
SCHEMBL15991273 0.70 ADRA2A (0.38) KDM4E
SCHEMBL8846784 0.70 CYP2A6 (0.35) KDM4EKMT2A
SCHEMBL17039216 0.70 ALDH1A1 (0.34) HTTKMT2A
SCHEMBL16861487 0.69
SCHEMBL236034 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688778-A1 1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-2-OXOPYRROLIDINE-3-CARBONITRILE DERIVATIVES AS TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES Biogen MA Inc. (US) 2026-02-11 EP disclosed
WO-2024211696-A1 1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-2-OXOPYRROLIDINE-3-CARBONITRILE DERIVATIVES AS TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES BIOGEN MA INC. (US) 2024-10-10 WO disclosed
CN-112574211-B Heterocyclic kinase inhibitors 山东轩竹医药科技有限公司 2022-06-14 CN disclosed
CN-112574211-A Heterocyclic kinase inhibitors 山东轩竹医药科技有限公司 2021-03-30 CN disclosed
CN-108473476-B Alkynyl heterocyclic compounds for inhibiting protein kinase activity 深圳市塔吉瑞生物医药有限公司 2021-02-19 CN disclosed